Robert Dorschner is a Dermatology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Ucsd Division Of Dermatology
8899 University Center Lane, Ste 350
La Jolla, CA 920930001
Telephone
858-822-3958Registry record last updated 26 Sept 2016.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
28.7%Azole Antifungal24.9%Ketoconazole100%Part D≥30 patientsLincosamide Antibacterial3.8%Clindamycin Phosphate100%Part D<11 patientsCancer & immunology
26.5%Interleukin-17A Antagonist9%Cosentyx Sensoready (2 Pens)100%Part D<11 patientsPhosphodiesterase 4 Inhibitor6%Otezla100%Part D<11 patients+ 3 more classes in this area
Dermatology
19.4%Corticosteroid12%Triamcinolone Acetonide71%Fluocinolone Acetonide30%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist7.4%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- The role of the ECRG4 in Host Defense of Staph Aureus Infection
University of California, San Diego
FY2024$151,890K08AR077734 - The role of the ECRG4 in Host Defense of Staph Aureus Infection
University of California, San Diego
FY2023$154,050K08AR077734 - The role of the ECRG4 in Host Defense of Staph Aureus Infection
University of California, San Diego
FY2022$154,050K08AR077734
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”